Association of FCRL3 genotypes with susceptibility of Iranian patients to rheumatoid arthritis

Immunol Invest. 2013;42(4):296-306. doi: 10.3109/08820139.2013.764314.

Abstract

Rheumatoid arthritis (RA) is a complex disease, the hallmark of which is synovial joint inflammation. The substantial contribution from genetic factors in susceptibility to RA has been well-defined. The Fc receptor-like3 (FCRL3) gene is one of the genes that have recently shown a significant association with RA. To determine the possible role of FCRL3-169 C/T and FCRL3-110 A/G gene polymorphisms in the development of RA in Iranian patients, 320 RA patients and 302 healthy subjects were genotyped by polymerase chain reaction-restriction fragment length polymorphism. No significant difference was found in genotype and allele frequencies of FCRL3-169 C/T between patients and controls. In contrast, at position -110 A/G, the frequency of the AA genotype and A allele was significantly decreased in RA patients compared to controls (p = 0.005). After Bonferroni correction for multiple testing, no significant correlations between FCRL3-169 C/T and -110 A/G polymorphism and laboratory and clinical features of the patients was observed. In conclusion, the results of this study showed a significant association between FCRL3-110 A/G polymorphism and susceptibility to RA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / genetics*
  • C-Reactive Protein / analysis
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Immunoglobulin Allotypes / blood
  • Iran
  • Male
  • Middle Aged
  • Peptides, Cyclic / immunology
  • Polymorphism, Single Nucleotide
  • Receptors, Immunologic / genetics*
  • Rheumatoid Factor / blood
  • White People / genetics
  • Young Adult

Substances

  • FCRL3 protein, human
  • Immunoglobulin Allotypes
  • Peptides, Cyclic
  • Receptors, Immunologic
  • cyclic citrullinated peptide
  • C-Reactive Protein
  • Rheumatoid Factor